Baseline characteristics | Non-report of depressive symptoms (n = 164) | Report of depressive symptoms (n = 175) | Statistics | p |
---|---|---|---|---|
Socio-demographic | Â | Â | Â | Â |
Age (years) (m(sd)) | 48.7 (12.3) | 46.0 (11.2) | t (337df) = 2.1 | 0.03 |
Female n (%) | 56 (34.1%) | 84 (48.0%) | Chi2 (1df) = 6.7 | 0.01 |
Higher secondary/university education n (%) | 88 (53.7%) | 74 (42.3%) | Chi2 (1df) = 4.4 | 0.04 |
Married/cohabiting n (%) | 122 (74.4%) | 115 (65.7%) | Chi2 (1df) = 3.0 | 0.08 |
Current professional activity n (%) | 50 (30.5%) | 36 (20.6%) | Chi2 (1df) = 4.4 | 0.04 |
Current leisure activities n (%) | 117 (71.8%) | 88 (50.6%) | Chi2 (1df) = 15.9 | 0.0007 |
Psychometric | Â | Â | Â | Â |
STAI (m(sd)) | 31.66 (7.24) | 42.38 (10.04) | t (337df) = -11.2 | < 10 -4 |
Medical data | Â | Â | Â | Â |
Main primary diagnosis | Â | Â | Chi2 (7df) = 8.72 | 0.27 |
Glomerulopathies n (%) | 35 (21.3%) | 52 (29.7%) | Â | Â |
Tubulointerstitial nephropathies n (%) | 8 (4.9%) | 13 (7.4%) | Â | Â |
Vascular nephropathies n (%) | 18 (11.0%) | 15 (8.6%) | Â | Â |
Other nephropathies n (%) | 27 (16.5%) | 19 (10.9%) | Â | Â |
Non cholestatic cirrhosis n (%) | 24 (14.6%) | 34 (19.4%) | Â | Â |
Hepatocellular carcinoma n (%) | 24 (14.6%) | 19 (10.9%) | Â | Â |
Metabolic diseases n (%) | 17 (10.4%) | 13 (7.4%) | Â | Â |
Other liver diseases n (%) | 11 (6.7%) | 10 (5.7%) | Â | Â |
Length since the main primary diagnosis | Â | Â | Chi2 (3df) = 2.0 | 0.56 |
<1 year n (%) | 10 (6.1%) | 18 (10.3%) | Â | Â |
1 to 5 years n (%) | 58 (35.4%) | 59 (33.9%) | Â | Â |
5 to 10 years n (%) | 38 (23.2%) | 37 (21.3%) | Â | Â |
>10 years n (%) | 58 (35.4%) | 60 (34.5%) | Â | Â |
UNOS score | Â | Â | Chi2 (2df) = 5.4 | 0.07 |
2 n (%) | 41 (25.0%) | 30 (17.1%) | Â | Â |
3 n (%) | 120 (73.2%) | 136 (77.7%) | Â | Â |
4 n (%) | 3 (1.8%) | 9 (5.1%) | Â | Â |
Current cigarette smoking | Â | Â | Chi2 (2df) = 13.05 | 0.001 |
No n (%) | 134 (81.7%) | 117 (66.9%) | Â | Â |
Occasional n (%) | 10 (6.1%) | 9 (5.1%) | Â | Â |
Daily n (%) | 20 (12.2%) | 49 (28.0%) | Â | Â |